Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2020

Nov 14, 2020

30071_dirs_2020-11-13_3d144c2b-d91e-4a8f-babf-bbea8825ccdd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-11-11

Reporting Person: Sodhi Rajwant (President, SaaS Business)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-11 ResMed Common Stock F 982 $212.11 Disposed 30180 Direct
2020-11-11 ResMed Common Stock F 1418 $212.11 Disposed 28762 Direct
2020-11-11 ResMed Common Stock F 1211 $212.11 Disposed 27551 Direct

Footnotes

F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017.

F2: Includes 72.85 shares of ResMed stock purchased on October 31, 2020, through the ResMed Employee Stock Purchase Plan.

F3: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018.

F4: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019.